Kaleido Biosciences Inc (KLDO)
0.00
USD |
OTCM |
Nov 13, 16:00
Kaleido Biosciences Max Drawdown (5Y): 100.0% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 100.0% |
| September 30, 2024 | 100.0% |
| August 31, 2024 | 100.0% |
| July 31, 2024 | 100.0% |
| June 30, 2024 | 100.0% |
| May 31, 2024 | 100.0% |
| April 30, 2024 | 100.0% |
| March 31, 2024 | 100.0% |
| February 29, 2024 | 100.0% |
| January 31, 2024 | 100.0% |
| December 31, 2023 | 100.0% |
| November 30, 2023 | 100.0% |
| October 31, 2023 | 100.0% |
| September 30, 2023 | 100.0% |
| August 31, 2023 | 100.0% |
| July 31, 2023 | 100.0% |
| June 30, 2023 | 100.0% |
| May 31, 2023 | 100.0% |
| April 30, 2023 | 100.00% |
| March 31, 2023 | 100.00% |
| February 28, 2023 | 100.00% |
| January 31, 2023 | 100.00% |
| December 31, 2022 | 100.00% |
| November 30, 2022 | 100.00% |
| October 31, 2022 | 100.00% |
| Date | Value |
|---|---|
| September 30, 2022 | 100.00% |
| August 31, 2022 | 100.00% |
| July 31, 2022 | 100.00% |
| June 30, 2022 | 99.73% |
| May 31, 2022 | 99.72% |
| April 30, 2022 | 99.72% |
| March 31, 2022 | 92.82% |
| February 28, 2022 | 91.88% |
| January 31, 2022 | 90.39% |
| December 31, 2021 | 86.80% |
| November 30, 2021 | 80.17% |
| October 31, 2021 | 80.00% |
| September 30, 2021 | 80.00% |
| August 31, 2021 | 80.00% |
| July 31, 2021 | 80.00% |
| June 30, 2021 | 80.00% |
| May 31, 2021 | 80.00% |
| April 30, 2021 | 80.00% |
| March 31, 2021 | 80.00% |
| February 28, 2021 | 80.00% |
| January 31, 2021 | 80.00% |
| December 31, 2020 | 80.00% |
| November 30, 2020 | 80.00% |
| October 31, 2020 | 80.00% |
| September 30, 2020 | 80.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
72.10%
Minimum
Nov 2019
100.0%
Maximum
May 2023
90.52%
Average
99.72%
Median
Apr 2022
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |